Erosive diseases of the vulva

Dermatologic Clinics

Volumn 28, Issue 4, 2010, Pages 737-751

  Pipkin, Clare ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dermatosis; Erosive; Genital; Lichen planus; Vulvar; Vulvitis

Indexed keywords

AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; CAPTOPRIL; CARBAMAZEPINE; CLOBETASOL PROPIONATE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DAPSONE; FLUCONAZOLE; FUROSEMIDE; GRISEOFULVIN; HYDROCORTISONE; IBUPROFEN; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENT; METRONIDAZOLE; NICOTINAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; STEROID; SULFONAMIDE; TACROLIMUS; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TRIAMCINOLONE;

BULLOUS PEMPHIGOID; CAUSAL ATTRIBUTION; CLINICAL EVALUATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG MEGADOSE; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; FIXED DRUG ERUPTION; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; IMPETIGO; IRRITANT DERMATITIS; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; MUCOUS MEMBRANE PEMPHIGOID; PARANEOPLASTIC PEMPHIGUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SKIN ALLERGY; SKIN BIOPSY; SKIN CANCER; SKIN FISSURE; STEVENS JOHNSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VAGINA CANDIDIASIS; VULVA DISEASE; VULVITIS;

CANDIDIASIS, VULVOVAGINAL; CARCINOMA, SQUAMOUS CELL; DERMATITIS; FEMALE; HERPESVIRIDAE INFECTIONS; HUMANS; IMPETIGO; LICHEN PLANUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SKIN DISEASES, VESICULOBULLOUS; VULVAR DISEASES; VULVAR LICHEN SCLEROSUS; VULVAR NEOPLASMS;

EID: 77957162086     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2010.08.005     Document Type: Review

References (55)

1. Cooper S.M., Ali I., Baldo M., et al. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008, 144:1432.
2. Lundqvist E.N., Wahlin Y.B., Bergdahl M., et al. Psychological health in patients with genital and oral erosive lichen planus. J Eur Acad Dermatol Venereol 2006, 20:661.
3. Margesson L.J. Vulvar disease pearls. Dermatol Clin 2006, 24:145.
4. Hansen A., Carr K., Jensen J.T. Characteristics and initial diagnoses in women presenting to a referral center for vulvovaginal disorders in 1996-2000. J Reprod Med 2002, 47:854.
5. Micheletti L., Preti M., Bogliatto F., et al. Vulval lichen planus in the practice of a vulval clinic. Br J Dermatol 2000, 143:1349.
6. Batta K., Munday P.E., Tatnall F.M. Pemphigus vulgaris localized to the vagina presenting as chronic vaginal discharge. Br J Dermatol 1999, 140:945.
7. Asarch A., Gottlieb A.B., Lee J., et al. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol 2009, 61:104.
8. Boyd A.S., Neldner K.H. Lichen planus. J Am Acad Dermatol 1991, 25:593.
9. Buell C., Koo J. Long-term safety of mycophenolate mofetil and cyclosporine: a review. J Drugs Dermatol 2008, 7:741.
10. Weedon D., Strutton G. Skin pathology 2002, New York, Churchill Livingstone, London. 2nd edition.
11. Kirtschig G., Wakelin S.H., Wojnarowska F. Mucosal vulval lichen planus: outcome, clinical and laboratory features. J Eur Acad Dermatol Venereol 2005, 19:301.
12. Goldstein A.T., Thaci D., Luger T. Topical calcineurin inhibitors for the treatment of vulvar dermatoses. Eur J Obstet Gynecol Reprod Biol 2009, 146:22.
13. Buyuk A.Y., Kavala M. Oral metronidazole treatment of lichen planus. J Am Acad Dermatol 2000, 43:260.
14. Camisa C., Allen C.M. Treatment of oral erosive lichen planus with systemic isotretinoin. Oral Surg Oral Med Oral Pathol 1986, 62:393.
15. Fivenson D.P., Mathes B. Treatment of generalized lichen planus with alefacept. Arch Dermatol 2006, 142:151.
16. Pacheco H., Kerdel F. Successful treatment of lichen planus with low-molecular-weight heparin: a case series of seven patients. J Dermatolog Treat 2001, 12:123.
17. Rogers R.S., Eisen D. Erosive oral lichen planus with genital lesions: the vulvovaginal-gingival syndrome and the peno-gingival syndrome. Dermatol Clin 2003, 21:91.
18. Smith Y.R., Haefner H.K. Vulvar lichen sclerosus: pathophysiology and treatment. Am J Clin Dermatol 2004, 5:105.
19. Shelley W.B., Shelley E.D. Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline. J Am Acad Dermatol 1987, 17:403.
20. Fischer G. Vulvar fixed drug eruption. A report of 13 cases. J Reprod Med 2007, 52:81.
21. Sehgal V.N., Srivastava G. Fixed drug eruption (FDE): changing scenario of incriminating drugs. Int J Dermatol 2006, 45:897.
22. Wain E.M., Neill S. Fixed drug eruption of the vulva secondary to fluconazole. Clin Exp Dermatol 2008, 33:784.
23. Bolognia J., Jorizzo J.L., Rapini R.P. Dermatology 2003, New York, Mosby, London.
24. Farage M.A. Vulvar susceptibility to contact irritants and allergens: a review. Arch Gynecol Obstet 2005, 272:167.
25. Haverhoek E., Reid C., Gordon L., et al. Prospective study of patch testing in patients with vulval pruritus. Australas J Dermatol 2008, 49:80.
26. Marren P., Wojnarowska F., Powell S. Allergic contact dermatitis and vulvar dermatoses. Br J Dermatol 1992, 126:52.
27. Yeh S.W., Ahmed B., Sami N., et al. Blistering disorders: diagnosis and treatment. Dermatol Ther 2003, 16:214.
28. Marren P., Wojnarowska F., Venning V., et al. Vulvar involvement in autoimmune bullous diseases. J Reprod Med 1993, 38:101.
29. Urano S. Localized bullous pemphigoid of the vulva. J Dermatol 1996, 23:580.
30. Farrell A.M., Kirtschig G., Dalziel K.L., et al. Childhood vulval pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol 1999, 140:308.
31. Hoque S.R., Patel M., Farrell A.M. Childhood cicatricial pemphigoid confined to the vulva. Clin Exp Dermatol 2006, 31:63.
32. Ahmed A.R., Hombal S.M. Cicatricial pemphigoid. Int J Dermatol 1986, 25:90.
33. Fleming T.E., Korman N.J. Cicatricial pemphigoid. J Am Acad Dermatol 2000, 43:571.
34. Chan L.S., Ahmed A.R., Anhalt G.J., et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002, 138:370.
35. Sacher C., Hunzelmann N. Cicatricial pemphigoid (mucous membrane pemphigoid): current and emerging therapeutic approaches. Am J Clin Dermatol 2005, 6:93.
36. Gibson G.E., Daoud M.S., Pittelkow M.R. Anti-epiligrin (laminin 5) cicatricial pemphigoid and lung carcinoma: coincidence or association?. Br J Dermatol 1997, 137:780.
37. Sadler E., Lazarova Z., Sarasombath P., et al. A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer. J Dermatol Sci 2007, 47:1.
38. Patricio P., Ferreira C., Gomes M.M., et al. Autoimmune bullous dermatoses: a review. Ann N Y Acad Sci 2009, 1173:203.
39. Vassileva S. Bullous systemic lupus erythematosus. Clin Dermatol 2004, 22:129.
40. Kettler A.H., Bean S.F., Duffy J.O., et al. Systemic lupus erythematosus presenting as a bullous eruption in a child. Arch Dermatol 1988, 124:1083.
41. Burge S.M., Frith P.A., Juniper R.P., et al. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol 1989, 121:727.
42. Jolly M., Patel P. Looking beyond the ordinary: genital lupus. Arthritis Rheum 2006, 55:821.
43. Gammon W.R., Briggaman R.A. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin 1993, 11:535.
44. Schmidt E., Hopfner B., Chen M., et al. Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol 2002, 147:592.
45. Edwards L. Genital dermatology atlas 2004, Lippincott Williams & Wilkins, Philadelphia.
46. Schmidt E., Hunzelmann N., Zillikens D., et al. Rituximab in refractory autoimmune bullous diseases. Clin Exp Dermatol 2006, 31:503.
47. Akhyani M., Chams-Davatchi C., Naraghi Z., et al. Cervicovaginal involvement in pemphigus vulgaris: a clinical study of 77 cases. Br J Dermatol 2008, 158:478.
48. Dvoretsky P.M., Bonfiglio T.A., Patten S.F., et al. Pemphigus vulgaris and microinvasive squamous-cell carcinoma of the uterine cervix. Acta Cytol 1985, 29:403.
49. Tilakaratne W., Dissanayake M. Paraneoplastic pemphigus: a case report and review of literature. Oral Dis 2005, 11:326.
50. Joly P., Richard C., Gilbert D., et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000, 43:619.
51. Eckert L.O., Hawes S.E., Stevens C.E., et al. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol 1998, 92:757.
52. Fischer G., Rogers M. Vulvar disease in children: a clinical audit of 130 cases. Pediatr Dermatol 2000, 17:1.
53. Lautenschlager S., Eichmann A. The heterogeneous clinical spectrum of genital herpes. Dermatology 2001, 202:211.
54. van Seters M., van Beurden M., ten Kate F.J., et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med 2008, 358:1465.
55. Lynch P.J., Edwards L. Genital dermatology 1994, Churchill Livingstone, New York.